Latest Pharma News

The latest pharmaceutical manufacturing news, updated daily.

What the future holds for pharma packaging

The introduction of new technologies over the last decade has paved the way for pharmaceutical packaging companies to explore new and innovative solutions, improve their operations and drive efficiencies across the supply chain. Here, Dexter Tjoa, di

By Dexter Tjoa

/ 30 May 2018

What the future holds for pharma packaging

Clopidogrel prescriptions could see a boost after release of trial results, says GlobalData

An increase in clopidogrel prescriptions could be seen in the US and Europe for secondary ischaemic stroke prevention as a result of the outcomes of the Phase III POINT trial, according to data and analytics company, GlobalData.

By PharmaManufacturingIQ Staff

/ 29 May 2018

Clopidogrel prescriptions could see a boost after release of trial results, says GlobalData

A long way to go… what are the next steps to protect public health from falsified medicines?

Five years on from the adoption of the EU falsified medicines directive (2011/62/EU) and the challenge continues. Here, Vincenzo Salvatore, BonelliErede (Milan), looks at the reasoning behind the directive and potential next steps

By Vincenzo Salvatore

/ 29 May 2018

A long way to go… what are the next steps to protect public health from falsified medicines?

Are you ready for serialisation? Three experts give their perspectives

After a preview of TraceLink’s second annual Global Drug Supply, Safety and Traceability survey has revealed disparity in terms of readiness for the FMD between pharma companies and CMOs, three experts give us their perspectives on serialisation

By PharmaManufacturingIQ Staff

/ 29 May 2018

Are you ready for serialisation? Three experts give their perspectives

For all practical purposes — key challenges and practical questions to achieving FMD compliance

As the falsified medicines directive is set to come into full force early next year, Christian Taylor, serialisation business consultant, Zetes, looks at the key challenges and practical questions relating to achieving compliance in more detail.

By Christian Taylor

/ 29 May 2018

For all practical purposes — key challenges and practical questions to achieving FMD compliance

Weighing it up… why aggregation is worth the consideration

In this article, Marco Baietti, commercial director at SEA Vision, weighs up the advantages of implementing aggregation, what the future holds and the current levels of adoption within the industry.

By Marco Baietti

/ 28 May 2018

Weighing it up… why aggregation is worth the consideration

Reducing the odds — how to prepare for the impact of big data

In this guide, Manuel Duval, PhD, from Scientist.com looks at how pharma and biopharma companies can best prepare for the impact of big data in healthcare.

By Manuel Duval

/ 28 May 2018

Reducing the odds — how to prepare for the impact of big data

Disrupt or be disrupted? Why blockchain will change your world

Here, Scott Allison, president, Life Sciences & Healthcare, DHL, and Keith Turner, CIO Chief Development Office, Life Sciences & Healthcare, Service Logistics, DHL Supply Chain, look at the importance of blockchain in logistics.

By PharmaManufacturingIQ Staff

/ 28 May 2018

Disrupt or be disrupted? Why blockchain will change your world

Bridging the gap between clinical development and patient access with real-world evidence

Here, Dr Chitra Lele, chief scientific officer at Sciformix Corporation discusses the real-world evidence's (RWE’s) continuum and how it could bridge the gap between clinical development and patient access.

By Chitra Lele

/ 28 May 2018

Bridging the gap between clinical development and patient access with real-world evidence

Reaction Biology partners with open science company to tackle rare paediatric brain cancer

Contract research organisation (CRO), Reaction Biology, has partnered with an open science drug discovery and development company, M4K Pharma, in the fight against diffuse intrinsic pontine glioma (DIPG) — a rare paediatric brain cancer.

By PharmaManufacturingIQ Staff

/ 25 May 2018

Reaction Biology partners with open science company to tackle rare paediatric brain cancer

Achieving the desired end goal: Best approaches to achieving Policy 0070 compliance

Pooja Phogat, regulation and compliance expert at Kinapse, advises on the best approaches to balancing the risk of patient re-identification with the need for greater data utility.

By Pooja Phogat

/ 25 May 2018

Achieving the desired end goal: Best approaches to achieving Policy 0070 compliance

Getting a handle on GDPR — what should you be aware of to be compliant?

As the General Data Protection Regulation (GDPR) take effect this month, Mark Stevens, managing director, Formpipe Life Science, looks at the key differences companies should be aware of and how they can attain compliance.

By Mark Stevens

/ 25 May 2018